Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T P Moyer

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1990
Amiodarone-induced injury of human pulmonary artery endothelial cells: protection by alpha-tocopherolD L Kachel, T P Moyer, W J Martin
Clinical Chemistry|May 1, 1991
Blood-collection device for trace and ultra-trace metal specimens evaluatedT P Moyer, G V Mussmann, D E Nixon
Mayo Clinic Proceedings|September 1, 1978
Laboratory medicine. Series on clinical testing. 2. Fractionation of urinary ketosteroids. Procedure and clinical significanceT P Moyer, P C Carpenter, N Jiang, et al.
Clinical Biochemistry|April 1, 1986
Cyclosporine: a review of drug monitoring problems and presentation of a simple, accurate liquid chromatographic procedure that solves these problemsT P Moyer, P Johnson, S M Faynor, et al.
Mayo Clinic Proceedings|October 1, 1982
The implications for antidepressant therapy of measurement of urinary MHPGT P Moyer, T Maruta, E Richelson, et al.
Transplantation Proceedings|September 1, 1982
Breast-feeding after renal transplantationC B Coulam, T P Moyer, N S Jiang, et al.
Transplantation Proceedings|February 1, 1987
Long-term cyclosporine for renal allograft patients does not cause nephrotoxicityG R Post, T P Moyer, C F Anderson, et al.
Mayo Clinic Proceedings|March 1, 1988
Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in bloodT P Moyer, G R Post, S Sterioff, et al.
Mayo Clinic Proceedings|July 1, 1994
Advances in liver biopsy diagnosisJ Ludwig, K P Batts, T P Moyer, et al.
Mayo Clinic Proceedings|August 1, 1984
Therapeutic drug monitoring of cyclosporineS M Faynor, T P Moyer, S Sterioff, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1990
Amiodarone-induced injury of human pulmonary artery endothelial cells: protection by alpha-tocopherolD L Kachel, T P Moyer, W J Martin
Clinical Chemistry|May 1, 1991
Blood-collection device for trace and ultra-trace metal specimens evaluatedT P Moyer, G V Mussmann, D E Nixon
Mayo Clinic Proceedings|September 1, 1978
Laboratory medicine. Series on clinical testing. 2. Fractionation of urinary ketosteroids. Procedure and clinical significanceT P Moyer, P C Carpenter, N Jiang, et al.
Clinical Biochemistry|April 1, 1986
Cyclosporine: a review of drug monitoring problems and presentation of a simple, accurate liquid chromatographic procedure that solves these problemsT P Moyer, P Johnson, S M Faynor, et al.
Mayo Clinic Proceedings|October 1, 1982
The implications for antidepressant therapy of measurement of urinary MHPGT P Moyer, T Maruta, E Richelson, et al.
Transplantation Proceedings|September 1, 1982
Breast-feeding after renal transplantationC B Coulam, T P Moyer, N S Jiang, et al.
Transplantation Proceedings|February 1, 1987
Long-term cyclosporine for renal allograft patients does not cause nephrotoxicityG R Post, T P Moyer, C F Anderson, et al.
Mayo Clinic Proceedings|March 1, 1988
Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in bloodT P Moyer, G R Post, S Sterioff, et al.
Mayo Clinic Proceedings|July 1, 1994
Advances in liver biopsy diagnosisJ Ludwig, K P Batts, T P Moyer, et al.
Mayo Clinic Proceedings|August 1, 1984
Therapeutic drug monitoring of cyclosporineS M Faynor, T P Moyer, S Sterioff, et al.
Pageof 8